심장 모니터링 및 심장박동관리 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Growth & Trends:

The global cardiac monitoring and cardiac rhythm management devices market size is expected to reach USD 33.29 billion by 2030, registering a CAGR of 7.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of cardiovascular diseases and advancement in medical devices is driving the market.

Cardiovascular disorders, such as ischemic heart disease, are one of the leading causes of death globally. According to the CDC, the prevalence of cardiovascular diseases and the number of deaths has remained steady with almost 31.0% of the population dying due to such diseases in 2017. Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese. In addition, in 2016, about 18.0% of the U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dL. Industry players are trying to develop advanced medical devices for cardiovascular disorders, which is propelling the market.

The hospital segment held the largest market share in terms of revenue in 2019. Hospitals are able to provide optimal care of the patients suffering from cardiovascular disorders by efficiently monitoring and diagnosing the problem at an early stage. This, in turn, is anticipated to augment the growth of the segment in the market.

The home care segment is expected to witness significant growth over the forecast period owing to ease of treatment and cost-effectiveness provided by the system. Miniaturization of medical devices required to monitor cardiovascular events at remote places is anticipated to drive the driving segment in the coming years.

North America held the largest revenue share in 2019 owing to the increasing geriatric population in the region. In addition, rapid technological advancements in medical devices such as miniaturization, long battery life, the use of biocompatible materials are also stimulating the growth of the market in the region. Moreover, rising cases of cardiovascular disorders including heart failure and cardiovascular arrests are expected to propel market growth in the region.

In Asia Pacific, the market is anticipated to witness significant growth over the forecast period. This is attributed to the rising demand for quality healthcare services in the region. The growing number of an aging population in countries including India, Japan, and China is driving demand for advanced medical devices in the region.

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Highlights:

• The cardiac rhythm management devices segment dominated the market with a revenue share of 66.0% in 2024 due to the increasing prevalence of cardiovascular diseases, particularly arrhythmias and heart failure.
• The hospitals segment dominated the market with the largest revenue share in 2024, which can be attributed to their capability to provide comprehensive care for patients with complex cardiac conditions.
• North America cardiac monitoring and cardiac rhythm management devices market held the highest revenue share of 47.0% in 2024 due to substantial healthcare spending and a well-developed medical infrastructure.
• The Asia Pacific cardiac monitoring and cardiac rhythm management devices market is expected to register the highest CAGR of 8.1% over the forecast period, which can be attributed to rapid urbanization and a rise in lifestyle-related diseases.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cardiac Monitoring Devices
  • 4.4.1. Cardiac Monitoring Devices Market, 2018 - 2030 (USD Million)
  • 4.4.2. ECG
    • 4.4.2.1. ECG Market, 2018 - 2030 (USD Million)
  • 4.4.3. Implantable Cardiac Monitors
    • 4.4.3.1. Implantable Cardiac Monitors Market, 2018 - 2030 (USD Million)
  • 4.4.4. Holter Monitors
    • 4.4.4.1. Holter Monitors Market, 2018 - 2030 (USD Million)
  • 4.4.5. Mobile Cardiac Telemetry
    • 4.4.5.1. Mobile Cardiac Telemetry Market, 2018 - 2030 (USD Million)
• 4.5. Cardiac Rhythm Management Devices
  • 4.5.1. Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
  • 4.5.2. Cardiac Resynchronization Therapy (CRT)
    • 4.5.2.1. Cardiac Resynchronization Therapy (CRT) Market, 2018 - 2030 (USD Million)
    • 4.5.2.2. CRT-Defibrillator
      • 4.5.2.2.1. CRT-Defibrillator Market, 2018 - 2030 (USD Million)
    • 4.5.2.3. CRT-Pacemakers
      • 4.5.2.3.1. CRT-Pacemakers Market, 2018 - 2030 (USD Million)
  • 4.5.3. Defibrillator
    • 4.5.3.1. Defibrillator Market, 2018 - 2030 (USD Million)
    • 4.5.3.2. Implantable Cardioverter Defibrillators (ICD)
      • 4.5.3.2.1. Implantable Cardioverter Defibrillators (ICD) Market, 2018 - 2030 (USD Million)
      • 4.5.3.2.2. Single Chamber
      • 4.5.3.2.3. Single Chamber Market, 2018 - 2030 (USD Million)
      • 4.5.3.2.4. Dual Chamber
      • 4.5.3.2.5. Dual Chamber Market, 2018 - 2030 (USD Million)
    • 4.5.3.3. External Defibrillator
      • 4.5.3.3.1. External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.2. Manual External Defibrillator
        • 4.5.3.3.2.1. Manual External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.3. Automatic External Defibrillator
        • 4.5.3.3.3.1. Automatic External Defibrillator Market, 2018 - 2030 (USD Million)
      • 4.5.3.3.4. Wearable Cardioverter Defibrillator
        • 4.5.3.3.4.1. Wearable Cardioverter Defibrillator Market, 2018 - 2030 (USD Million)
  • 4.5.4. Pacemakers
    • 4.5.4.1. Pacemakers Market, 2018 - 2030 (USD Million)
    • 4.5.4.2. Conventional
      • 4.5.4.2.1. Conventional Market, 2018 - 2030 (USD Million)
    • 4.5.4.3. Leadless
      • 4.5.4.3.1. Leadless Market, 2018 - 2030 (USD Million)

Chapter 5. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.5. Ambulatory Surgery Centers
  • 5.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Cardiac Monitoring and Cardiac Rhythm Management Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Canada Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Cardiac Monitoring and Cardiac Rhythm Management Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Stryker
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Abbott
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Boston Scientific Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Koninklijke Philips N.V.
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. ZOLL Medical Corporation.
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. GE HealthCare
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. MicroPort Scientific Corporation
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. NIHON KOHDEN CORPORATION
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. BioTelemetry
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives